We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHTX icon
3151
Foghorn Therapeutics
FHTX
$400M
$139K ﹤0.01%
9,153
-12,183
-57% -$167K
LGVCW
3152
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$139K ﹤0.01%
+533,773
New +$197K
CVRX icon
3153
CVRx
CVRX
$66.1M
$137K ﹤0.01%
+22,927
New +$185K
EZPW icon
3154
Ezcorp Inc
EZPW
$1.67B
$137K ﹤0.01%
22,696
-73,969
-77% -$461K
TTI icon
3155
TETRA Technologies
TTI
$1.29B
$137K ﹤0.01%
33,381
-87,304
-72% -$279K
TK icon
3156
Teekay
TK
$958M
$136K ﹤0.01%
42,931
+31,299
+269% +$101K
TRMD icon
3157
TORM
TRMD
$2.91B
$136K ﹤0.01%
+15,399
New +$121K
CYTK icon
3158
Cytokinetics
CYTK
$10.7B
$134K ﹤0.01%
3,627
-102,224
-97% -$3.63M
OSW icon
3159
OneSpaWorld
OSW
$2.65B
$134K ﹤0.01%
13,164
-3,752
-22% -$38.2K
PEPLW
3160
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$134K ﹤0.01%
+323,735
New +$140K
FSRX
3161
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
$134K ﹤0.01%
+13,688
New +$133K
PRVB
3162
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$133K ﹤0.01%
18,114
-728
-4% -$4.35K
FRONU
3163
DELISTED
Frontier Acquisition Corp. Units
FRONU
$133K ﹤0.01%
13,514
+2,622
+24% +$25.9K
WEBR
3164
DELISTED
Weber Inc.
WEBR
$132K ﹤0.01%
13,389
-27,372
-67% -$295K
MCBC
3165
DELISTED
Macatawa Bank Corp
MCBC
$131K ﹤0.01%
+14,559
New +$134K
POL
3166
DELISTED
Polished.com Inc.
POL
$131K ﹤0.01%
1,368
+758
+124% +$74.5K
SLVRU
3167
DELISTED
SilverSPAC Inc. Unit
SLVRU
$131K ﹤0.01%
13,285
-17,095
-56% -$168K
PICC
3168
DELISTED
Pivotal Investment Corporation III
PICC
$131K ﹤0.01%
+13,433
New +$131K
CUE icon
3169
Cue Biopharma
CUE
$107M
$130K ﹤0.01%
+888
New +$188K
ONYXW
3170
DELISTED
Onyx Acquisition Co. I Warrant
ONYXW
$130K ﹤0.01%
+383,288
New +$132K
GETR
3171
DELISTED
Getaround, Inc.
GETR
$130K ﹤0.01%
+13,299
New +$129K
CBRGW
3172
DELISTED
Chain Bridge I Warrants
CBRGW
$130K ﹤0.01%
+360,726
New +$151K
PLRX icon
3173
Pliant Therapeutics
PLRX
$65.6M
$129K ﹤0.01%
18,414
+7,539
+69% +$76.9K
SCAQ
3174
DELISTED
Stratim Cloud Acquisition Corp. Class A Common Stock
SCAQ
$129K ﹤0.01%
+13,191
New +$128K
GATEU
3175
DELISTED
Marblegate Acquisition Corp. Unit
GATEU
$128K ﹤0.01%
12,902
-27,438
-68% -$273K

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.